ACXP - Acurx Pharmaceuticals GAAP EPS of -$0.26 August, 15 2022 08:19 AM Acurx Pharmaceuticals Inc. Acurx Pharmaceuticals press release ( NASDAQ: ACXP ): Q2 GAAP EPS of -$0.26. The company ended the second quarter on Jun 30, 2022, with cash totaling $9.1M compared to $13.1M as of Dec. 31, 2021. For further details see: Acurx Pharmaceuticals GAAP EPS of -$0.26